Zahora N Ally, MD
Radiation Oncology · Antioch
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 2 carriers
- Office
- 1
- Since medical school
- 27 years
- Graduated 1999
Offices
1 location · Epic Care · 54 clinicians in this group
Hospitals listed: Contra Costa Regional Medical Center · John Muir Medical Center - Walnut Creek Campus · Sutter Delta Medical Center. That is not proof they admit you there this week.
Plans that list them
10 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ally’s office at (925) 778-0679 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
State licence records
1 licence
- Florida ME89834Medical Doctor · since 2004 · expires 2028-01-31InactiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
2 placements
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- Radiation Oncology
Education
- Mcmaster University · MD1996–1999Medical school
Residency and fellowship
- Howard University Hospital, Radiation OncologyWASHINGTON, DC · 2001–2005
- York Hospital, Internal MedicineYORK, PA · 1999–2000
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Contra Costa Regional Medical CenterMartinez, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Contra Costa Health ServicesPatients rate it 3 of 5 · 73% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.167, Oct 2024 – Sep 2025
- John Muir Medical Center - Walnut Creek CampusWalnut Creek, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Abdominopelvic accidental puncture or laceration rate: 2.01 (1.17 to 2.85) · 2,206 cases, Jul 2022 – Jun 2024Worse than the national rate — Death rate among surgical inpatients with serious treatable complications: 222.42 (177.82 to 267.02) · 120 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.4 (0.91 to 1.9) · 9,764 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Colon Surgery: 2.734, Oct 2024 – Sep 2025Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.536, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.341, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.455, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.245, Oct 2024 – Sep 2025
- Sutter Delta Medical CenterAntioch, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.173, Oct 2024 – Sep 2025
See every measure and the patient survey for Contra Costa Regional Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 1 better, 4 the same, 1 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.167 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.99 (0 to 2.04) · 188 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.08 (0.63 to 1.53) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.8 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 114 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.3 · 27 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 321 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 1,181 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,198 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.2 (0.67 to 5.72) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 71 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.5 (0.82 to 4.18) · 195 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.36 (1.01 to 19.71) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.08) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.07 (0.55 to 3.58) · 67 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.93 (0 to 2.03) · 981 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.948 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 2.027 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.3 · 101 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 52.2 · 126 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -53.6 · 112 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 87 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.6) · 95 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (8.8 to 17.8) · 95 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 35 cases | None | Jul 2023 – Jun 2025 |
What patients said (521 patients answered, 10% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 54% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for John Muir Medical Center - Walnut Creek Campus
Behind the star rating — Deaths: 3 better, 2 the same, 2 worse of 7 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 3 better, 5 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 2.01 (1.17 to 2.85) · 2,206 cases | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 222.42 (177.82 to 267.02) · 120 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.4 (0.91 to 1.9) · 9,764 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 2.734 | Worse | Oct 2024 – Sep 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.536 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.341 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.455 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.245 | Better | Oct 2024 – Sep 2025 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.87 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 131 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 695 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.5 · 827 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.1 · 509 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 4,483 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.35 (0.18 to 0.53) · 11,630 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.05 to 0.39) · 11,793 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.69 to 4.96) · 3,268 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.37 (0 to 2.94) · 1,631 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.76 (1.43 to 4.09) · 3,066 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.12 (0.22 to 12.02) · 1,580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.43 (1.21 to 7.64) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 685 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 615 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 1.88 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 93 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 729 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.1 · 91 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13 · 736 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 34.8 · 842 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 818 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.4) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.2 to 15.5) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 584 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 139 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.9) · 222 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 321 cases | No different | Jan 2024 – Dec 2024 |
What patients said (758 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Sutter Delta Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.173 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.03) · 561 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.47 to 1.29) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 176.46 (114.75 to 238.17) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 113 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.3 · 260 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.5 · 56 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 1,274 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 3,285 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 3,374 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.47 (1.02 to 5.93) · 364 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.16 (0.49 to 3.83) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.63 (0 to 18.4) · 26 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.2 to 3.22) · 81 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.24 (0 to 1.07) · 2,713 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.962 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 116 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 316 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 20 · 83 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 7.1 · 298 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 27.3 · 269 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 283 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.7 to 17.1) · 529 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 45 cases | No different | Jan 2024 – Dec 2024 |
What patients said (610 patients answered, 13% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 70% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 60% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 64% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$1,233,696
Medicare paid this office $1,233,696 for 275 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatme | 74 | $333,288 | $2,315 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 41 | $140,437 | $411 |
| Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment | 41 | $135,408 | $3,149 |
| Ct guidance for insertion of radiation therapy fields | 84 | $71,653 | $127 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 23 | $49,626 | $1,838 |
See all 30 services
| Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatme | 74 | $333,288 | $2,315 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 41 | $140,437 | $411 |
| Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment | 41 | $135,408 | $3,149 |
| Ct guidance for insertion of radiation therapy fields | 84 | $71,653 | $127 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 23 | $49,626 | $1,838 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 31 | $43,640 | $264 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 30 | $42,988 | $265 |
| Design and construction of complex radiation treatment device | 82 | $42,956 | $134 |
| High precision radiation therapy planning | 18 | $41,093 | $2,055 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 85 | $37,041 | $304 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 44 | $30,805 | $497 |
| Calculation of radiation therapy dose | 62 | $29,507 | $70 |
| 3d radiation therapy planning | 36 | $25,626 | $513 |
| Radiation treatment management, 5 treatment sessions | 57 | $23,994 | $183 |
| Management of cranial lesion surgery using radiation over multiple sessions | 33 | $20,110 | $609 |
| Continuing radiation therapy consultation per week | 88 | $16,590 | $101 |
| Return visit (30+ min) | 69 | $14,552 | $124 |
| Complex radiation therapy planning | 77 | $14,255 | $158 |
| Short return visit (20+ min) | 83 | $11,504 | $88 |
| Design and construction of radiation treatment device for high precision radiation therapy | 19 | $10,977 | $499 |
| New patient visit (60+ min) | 50 | $9,991 | $200 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 27 | $9,733 | $295 |
| Telephone medical discussion with physician, 11-20 minutes | 50 | $6,812 | $84 |
| Telephone medical discussion with physician, 21-30 minutes | 35 | $5,789 | $123 |
| Special radiation treatment | 33 | $5,745 | $144 |
| Obtaining respiratory data needed to develop the optimal radiation treatment | 11 | $5,446 | $454 |
| Special medical radiation therapy consultation | 22 | $4,429 | $164 |
| Ct scan of chest with contrast | 14 | $2,759 | $172 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 16 | $186 | $0 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 16 | $129 | $8 |
Who their Medicare patients are
275 Original Medicare patients in 2024. Average age 75 · Under 65 8% · 85 and older 13% · Women 62% · Also on Medicaid 40% · Health risk score 2.16. Sicker patients than 9 in 10 peers; the typical radiation oncology clinician is at 1.69.
Conditions among them: High blood pressure 75% · Cancer 75% · Diabetes 36% · Chronic kidney disease 27% · Coronary heart disease 24% · COPD 24% · Depression 19% · Heart failure 18% · Atrial fibrillation 15% · Stroke 11% · Dementia 9%.
The office billed $6,297,884, Medicare allowed $1,541,096 and paid $1,233,696; for 6,455 services of 58 kinds; $389 of it was for drugs given in the office and $1,233,308 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 275 | 6,455 | 75 | 2.16 | $6,297,884 | $1,233,696 |
| 2023 | 270 | 7,600 | 74 | 1.87 | $5,564,084 | $1,146,584 |
| 2022 | 251 | 7,384 | 74 | 1.87 | $4,594,537 | $1,172,423 |
| 2021 | 263 | 7,751 | 75 | 1.85 | $4,753,751 | $1,087,673 |
| 2020 | 195 | 5,703 | 73 | 1.70 | $2,432,228 | $645,122 |
| 2019 | 243 | 5,082 | 73 | 1.81 | $3,226,300 | $839,097 |
| 2018 | 230 | 5,950 | 74 | 1.85 | $3,718,929 | $972,470 |
| 2017 | 232 | 5,268 | 73 | 1.84 | $3,019,231 | $769,206 |
| 2016 | 233 | 6,565 | 73 | 1.82 | $3,103,897 | $795,572 |
| 2015 | 224 | 6,096 | 73 | 1.86 | $3,455,899 | $882,235 |
| 2014 | 182 | 4,833 | 73 | 1.64 | $3,548,450 | $833,945 |
| 2013 | 227 | 5,925 | 74 | 1.50 | $4,059,893 | $818,581 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 32 services
| Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatme | 62 | $302,774 | $2,311 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 58 | $220,314 | $393 |
| Ct guidance for insertion of radiation therapy fields | 89 | $90,660 | $125 |
| Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment | 19 | $57,986 | $3,052 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 26 | $57,586 | $1,745 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 34 | $40,711 | $261 |
| High precision radiation therapy planning | 17 | $33,536 | $1,973 |
| Design and construction of complex radiation treatment device | 59 | $33,530 | $129 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 47 | $33,529 | $486 |
| Radiation treatment management, 5 treatment sessions | 64 | $29,583 | $179 |
| Calculation of radiation therapy dose | 64 | $23,155 | $67 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 16 | $23,133 | $263 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 48 | $18,119 | $283 |
| Continuing radiation therapy consultation per week | 82 | $17,379 | $94 |
| 3d radiation therapy planning | 31 | $16,795 | $480 |
| Management of cranial lesion surgery using radiation over multiple sessions | 20 | $11,922 | $596 |
| Short return visit (20+ min) | 85 | $11,354 | $81 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 29 | $10,936 | $288 |
| Return visit (30+ min) | 61 | $10,252 | $115 |
| Design and construction of radiation treatment device for high precision radiation therapy | 20 | $9,840 | $469 |
| New patient visit (60+ min) | 49 | $9,435 | $193 |
| Complex radiation therapy planning | 53 | $9,380 | $156 |
| Ct scan of abdomen and pelvis with contrast | 14 | $5,474 | $322 |
| Telephone medical discussion with physician, 11-20 minutes | 59 | $5,285 | $55 |
| Ct scan of chest with contrast | 24 | $5,218 | $180 |
| Obtaining respiratory data needed to develop the optimal radiation treatment | 11 | $4,871 | $443 |
| Telephone medical discussion with physician, 21-30 minutes | 36 | $4,460 | $86 |
| Special radiation treatment | 22 | $3,534 | $136 |
| Special medical radiation therapy consultation | 22 | $3,500 | $146 |
| Telephone medical discussion with physician, 5-10 minutes | 16 | $606 | $32 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 25 | $436 | $0 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 22 | $221 | $8 |
2022: 31 services
| Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatme | 70 | $313,480 | $2,305 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 56 | $208,114 | $398 |
| Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment | 32 | $106,411 | $3,130 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 35 | $76,099 | $1,691 |
| Ct guidance for insertion of radiation therapy fields | 77 | $74,770 | $125 |
| High precision radiation therapy planning | 29 | $55,700 | $1,921 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 18 | $34,698 | $246 |
| Radiation treatment management, 5 treatment sessions | 53 | $24,355 | $174 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 37 | $22,603 | $481 |
| Calculation of radiation therapy dose | 68 | $21,761 | $65 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 61 | $20,507 | $277 |
| Design and construction of complex radiation treatment device | 61 | $20,498 | $125 |
| Management of cranial lesion surgery using radiation over multiple sessions | 29 | $16,975 | $585 |
| Design and construction of radiation treatment device for high precision radiation therapy | 30 | $15,980 | $457 |
| Continuing radiation therapy consultation per week | 78 | $14,509 | $86 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 33 | $12,310 | $286 |
| 3d radiation therapy planning | 24 | $11,957 | $478 |
| Return visit (30+ min) | 74 | $11,699 | $122 |
| Complex radiation therapy planning | 56 | $9,174 | $153 |
| New patient visit (60+ min) | 39 | $7,876 | $202 |
| Short return visit (20+ min) | 65 | $7,573 | $85 |
| Ct scan of abdomen and pelvis with contrast | 15 | $5,769 | $339 |
| Obtaining respiratory data needed to develop the optimal radiation treatment | 12 | $5,708 | $439 |
| Telephone medical discussion with physician, 11-20 minutes | 51 | $5,293 | $65 |
| Special medical radiation therapy consultation | 33 | $5,189 | $140 |
| Ct scan of chest with contrast | 23 | $4,872 | $180 |
| Special radiation treatment | 32 | $4,479 | $128 |
| Telephone medical discussion with physician, 21-30 minutes | 28 | $3,913 | $100 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 28 | $314 | $8 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 26 | $307 | $0 |
| Insertion of needle into vein for collection of blood sample | 13 | $53 | $3 |
2021: 35 services
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 44 | $190,154 | $411 |
| Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatme | 37 | $146,652 | $2,328 |
| Ct guidance for insertion of radiation therapy fields | 84 | $96,381 | $128 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 36 | $82,709 | $271 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 35 | $58,354 | $281 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 23 | $49,062 | $1,692 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 60 | $44,302 | $515 |
| Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment | 12 | $41,184 | $3,168 |
| Design and construction of complex radiation treatment device | 79 | $41,007 | $126 |
| High precision radiation therapy planning | 18 | $37,900 | $1,995 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 64 | $34,200 | $295 |
| Radiation treatment management, 5 treatment sessions | 64 | $32,123 | $174 |
| Calculation of radiation therapy dose | 61 | $21,876 | $66 |
| Continuing radiation therapy consultation per week | 76 | $17,568 | $86 |
| New patient visit (60+ min) | 78 | $16,225 | $208 |
| 3d radiation therapy planning | 30 | $15,705 | $491 |
| Complex radiation therapy planning | 77 | $13,471 | $150 |
| Telephone medical discussion with physician, 21-30 minutes | 60 | $11,455 | $121 |
| Return visit (30+ min) | 69 | $10,346 | $116 |
| Design and construction of radiation treatment device for high precision radiation therapy | 18 | $10,066 | $479 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 23 | $8,308 | $286 |
| Complex radiation therapy planning for delivery of external radiation | 24 | $7,860 | $281 |
| Management of cranial lesion surgery using radiation over multiple sessions | 12 | $7,644 | $588 |
| Telephone medical discussion with physician, 11-20 minutes | 53 | $6,540 | $87 |
| Obtaining respiratory data needed to develop the optimal radiation treatment | 12 | $5,643 | $470 |
| Short return visit (20+ min) | 44 | $4,703 | $86 |
| Special radiation treatment | 35 | $4,625 | $122 |
| Ct scan of abdomen and pelvis with contrast | 13 | $4,482 | $345 |
| Special medical radiation therapy consultation | 25 | $3,853 | $133 |
| Ct scan of chest with contrast | 17 | $3,367 | $168 |
| Long return visit (40+ min) | 15 | $2,612 | $174 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 23 | $225 | $8 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 18 | $219 | $0 |
| Blood test, comprehensive group of blood chemicals | 15 | $180 | $11 |
| Insertion of needle into vein for collection of blood sample | 14 | $51 | $3 |
2020: 28 services
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 39 | $160,208 | $390 |
| Ct guidance for insertion of radiation therapy fields | 60 | $63,356 | $124 |
| Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatme | 11 | $48,929 | $2,224 |
| High precision radiation therapy planning | 20 | $43,655 | $1,984 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 28 | $40,411 | $277 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 21 | $33,975 | $1,618 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 18 | $28,689 | $271 |
| Design and construction of complex radiation treatment device | 59 | $26,909 | $126 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 44 | $20,898 | $290 |
| Radiation treatment management, 5 treatment sessions | 51 | $18,725 | $175 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 27 | $18,304 | $508 |
| Calculation of radiation therapy dose | 42 | $12,950 | $66 |
| Design and construction of radiation treatment device for high precision radiation therapy | 20 | $12,196 | $488 |
| Continuing radiation therapy consultation per week | 55 | $9,677 | $84 |
| 3d radiation therapy planning | 19 | $9,264 | $488 |
| New patient visit (60+ min) | 48 | $9,233 | $192 |
| Complex radiation therapy planning | 53 | $8,971 | $150 |
| Return visit (30+ min) | 47 | $5,632 | $91 |
| Complex radiation therapy planning for delivery of external radiation | 14 | $4,862 | $286 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 22 | $4,376 | $199 |
| Telephone medical discussion with physician, 21-30 minutes | 25 | $3,314 | $104 |
| Short return visit (20+ min) | 44 | $3,273 | $63 |
| Telephone medical discussion with physician, 11-20 minutes | 26 | $2,313 | $70 |
| Special radiation treatment | 18 | $2,170 | $121 |
| Special medical radiation therapy consultation | 15 | $1,967 | $131 |
| Injection, gadobutrol, 0.1 ml | 13 | $534 | $0 |
| X-ray during radiation therapy | 11 | $190 | $12 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 13 | $114 | $0 |
2019: 25 services
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 59 | $237,175 | $379 |
| Ct guidance for insertion of radiation therapy fields | 84 | $89,040 | $122 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 52 | $86,252 | $280 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 33 | $47,111 | $280 |
| High precision radiation therapy planning | 22 | $46,972 | $1,957 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 26 | $43,264 | $1,545 |
| Design and construction of complex radiation treatment device | 70 | $38,380 | $128 |
| Radiation treatment management, 5 treatment sessions | 80 | $37,171 | $173 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 39 | $27,551 | $530 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 58 | $26,392 | $287 |
| Calculation of radiation therapy dose | 50 | $18,347 | $66 |
| Continuing radiation therapy consultation per week | 82 | $18,299 | $84 |
| Design and construction of radiation treatment device for high precision radiation therapy | 25 | $13,684 | $489 |
| New patient visit (60+ min) | 67 | $12,768 | $191 |
| 3d radiation therapy planning | 25 | $12,760 | $491 |
| Complex radiation therapy planning | 65 | $10,330 | $150 |
| Return visit (30+ min) | 56 | $6,907 | $99 |
| Complex radiation therapy planning for delivery of external radiation | 21 | $6,873 | $286 |
| Short return visit (20+ min) | 61 | $5,177 | $66 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 25 | $5,149 | $198 |
| Special medical radiation therapy consultation | 22 | $2,861 | $130 |
| Special radiation treatment | 13 | $1,622 | $125 |
| X-ray during radiation therapy | 28 | $545 | $12 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 15 | $135 | $8 |
| Insertion of needle into vein for collection of blood sample | 15 | $50 | $3 |
2018: 26 services
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 72 | $295,602 | $371 |
| Ct guidance for insertion of radiation therapy fields | 98 | $107,326 | $120 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 38 | $65,796 | $285 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 32 | $61,210 | $282 |
| High precision radiation therapy planning | 22 | $51,024 | $2,041 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 26 | $47,634 | $1,537 |
| Radiation treatment management, 5 treatment sessions | 88 | $46,290 | $168 |
| Design and construction of complex radiation treatment device | 68 | $40,196 | $128 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 40 | $28,250 | $543 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 52 | $22,812 | $292 |
| Continuing radiation therapy consultation per week | 88 | $22,693 | $84 |
| Calculation of radiation therapy dose | 51 | $22,185 | $66 |
| 3d radiation therapy planning | 27 | $13,794 | $493 |
| Design and construction of radiation treatment device for high precision radiation therapy | 22 | $13,298 | $511 |
| New patient visit (60+ min) | 60 | $11,331 | $189 |
| Return visit (30+ min) | 78 | $11,253 | $96 |
| Complex radiation therapy planning | 59 | $9,998 | $149 |
| Complex radiation therapy planning for delivery of external radiation | 19 | $6,224 | $283 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 26 | $5,649 | $182 |
| Short return visit (20+ min) | 61 | $4,714 | $65 |
| Special radiation treatment | 17 | $2,329 | $123 |
| Special medical radiation therapy consultation | 12 | $1,810 | $129 |
| Long return visit (40+ min) | 13 | $1,635 | $117 |
| X-ray during radiation therapy | 20 | $375 | $12 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 16 | $197 | $9 |
| Insertion of needle into vein for collection of blood sample | 16 | $71 | $3 |
2017: 29 services
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 58 | $173,379 | $353 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 51 | $93,964 | $271 |
| Ct guidance for insertion of radiation therapy fields | 73 | $62,060 | $114 |
| Design and construction of complex radiation treatment device | 63 | $40,333 | $122 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 20 | $37,561 | $1,445 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 18 | $36,608 | $271 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 46 | $31,770 | $512 |
| High precision radiation therapy planning | 16 | $29,323 | $1,833 |
| Radiation treatment management, 5 treatment sessions | 88 | $28,973 | $165 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 56 | $27,054 | $273 |
| Calculation of radiation therapy dose | 50 | $19,353 | $62 |
| 3d radiation therapy planning | 33 | $15,633 | $460 |
| Continuing radiation therapy consultation per week | 93 | $15,312 | $80 |
| New patient visit (60+ min) | 58 | $10,588 | $183 |
| Design and construction of radiation treatment device for high precision radiation therapy | 15 | $9,328 | $491 |
| Long return visit (40+ min) | 54 | $8,940 | $124 |
| Complex radiation therapy planning | 57 | $8,194 | $144 |
| Return visit (30+ min) | 57 | $6,217 | $90 |
| Complex radiation therapy planning for delivery of external radiation | 21 | $6,080 | $276 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 22 | $5,380 | $186 |
| Ct scan of chest with contrast | 14 | $3,296 | $220 |
| Special radiation treatment | 20 | $2,671 | $134 |
| Special medical radiation therapy consultation | 20 | $2,583 | $123 |
| Short return visit (20+ min) | 24 | $1,721 | $61 |
| X-ray during radiation therapy | 24 | $408 | $11 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 19 | $209 | $10 |
| Blood test, comprehensive group of blood chemicals | 16 | $205 | $12 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 15 | $164 | $0 |
| Insertion of needle into vein for collection of blood sample | 16 | $50 | $3 |
2016: 28 services
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 49 | $203,259 | $341 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 47 | $78,735 | $262 |
| Ct guidance for insertion of radiation therapy fields | 65 | $70,144 | $110 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 32 | $52,659 | $261 |
| High precision radiation therapy planning | 20 | $43,539 | $1,893 |
| Radiation treatment management, 5 treatment sessions | 99 | $39,696 | $160 |
| Design and construction of complex radiation treatment device | 65 | $34,310 | $144 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 70 | $27,729 | $267 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 39 | $24,683 | $504 |
| Continuing radiation therapy consultation per week | 102 | $19,658 | $77 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 12 | $17,804 | $1,370 |
| Calculation of radiation therapy dose | 52 | $15,471 | $62 |
| Nuclear medicine study whole body with ct scan | 12 | $15,178 | $1,265 |
| Design and construction of radiation treatment device for high precision radiation therapy | 21 | $12,423 | $478 |
| New patient visit (60+ min) | 67 | $11,649 | $174 |
| 3d radiation therapy planning | 19 | $8,753 | $461 |
| Complex radiation therapy planning | 57 | $8,711 | $143 |
| Return visit (30+ min) | 58 | $6,890 | $87 |
| Short return visit (20+ min) | 65 | $5,386 | $61 |
| Ct scan of chest with contrast | 23 | $5,101 | $213 |
| Ct scan of abdomen and pelvis with contrast | 17 | $5,046 | $297 |
| Long return visit (40+ min) | 37 | $4,748 | $113 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 22 | $4,343 | $189 |
| Complex radiation therapy planning for delivery of external radiation | 15 | $4,030 | $269 |
| Design and construction of simple radiation treatment device | 15 | $2,927 | $77 |
| Special radiation treatment | 16 | $2,140 | $134 |
| X-ray during radiation therapy | 26 | $516 | $11 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 22 | $278 | $0 |
2015: 34 services
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 45 | $230,440 | $392 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 54 | $88,510 | $225 |
| Ct guidance for insertion of radiation therapy fields | 69 | $72,840 | $110 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 44 | $68,162 | $251 |
| Design and construction of complex radiation treatment device | 81 | $58,567 | $138 |
| Radiation treatment management, 5 treatment sessions | 106 | $45,348 | $159 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 58 | $40,420 | $481 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 92 | $36,106 | $260 |
| High precision radiation therapy planning | 15 | $33,519 | $1,862 |
| Continuing radiation therapy consultation per week | 107 | $21,587 | $75 |
| Calculation of radiation therapy dose | 55 | $20,983 | $57 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 12 | $17,880 | $1,375 |
| 3d radiation therapy planning | 33 | $15,671 | $448 |
| Complex radiation therapy planning | 69 | $11,978 | $135 |
| New patient visit (60+ min) | 68 | $11,952 | $176 |
| Complex radiation therapy planning for delivery of external radiation | 28 | $9,806 | $258 |
| Design and construction of radiation treatment device for high precision radiation therapy | 15 | $8,949 | $471 |
| Long return visit (40+ min) | 39 | $6,343 | $129 |
| Return visit (30+ min) | 55 | $5,702 | $86 |
| Short return visit (20+ min) | 63 | $4,989 | $61 |
| Special radiation treatment | 31 | $4,458 | $135 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 16 | $3,734 | $197 |
| Ct scan of abdomen and pelvis with contrast | 11 | $3,560 | $297 |
| Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 22 | $2,787 | $71 |
| Ct scan of chest with contrast | 12 | $2,643 | $203 |
| Special medical radiation therapy consultation | 12 | $1,607 | $115 |
| Special radiation therapy planning for delivery of external radiation | 15 | $1,358 | $85 |
| Design and construction of simple radiation treatment device | 13 | $1,172 | $78 |
| Special radiation therapy planning | 11 | $1,091 | $57 |
| X-ray during radiation therapy | 36 | $561 | $10 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 13 | $203 | $0 |
| Blood test, comprehensive group of blood chemicals | 12 | $190 | $12 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 16 | $187 | $10 |
| Insertion of needle into vein for collection of blood sample | 14 | $53 | $3 |
2014: 26 services
| Intensity modulated radiation treatment delivery per session | 39 | $214,986 | $389 |
| Radiation treatment delivery, three or more treatment areas | 43 | $85,119 | $221 |
| Radiation treatment delivery, three or more treatment areas | 26 | $67,967 | $244 |
| Ct guidance for insertion of radiation therapy fields | 48 | $60,988 | $115 |
| Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatme | 11 | $58,661 | $2,666 |
| Design and construction of complex radiation treatment device | 69 | $51,520 | $140 |
| Radiation treatment management, 5 treatment sessions | 83 | $40,195 | $159 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 62 | $38,157 | $483 |
| Calculation of radiation therapy dose | 52 | $28,121 | $62 |
| High precision radiation therapy planning | 13 | $28,114 | $1,874 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 56 | $19,977 | $263 |
| Continuing radiation therapy consultation per week | 84 | $18,335 | $73 |
| 3d radiation therapy planning | 27 | $13,915 | $449 |
| New patient visit (60+ min) | 48 | $8,427 | $176 |
| Complex radiation therapy planning | 48 | $8,315 | $139 |
| Return visit (30+ min) | 53 | $7,387 | $91 |
| Design and construction of radiation treatment device for high precision radiation therapy | 13 | $6,513 | $465 |
| Long return visit (40+ min) | 34 | $4,859 | $121 |
| Short return visit (20+ min) | 50 | $4,364 | $62 |
| Special radiation treatment | 23 | $3,751 | $139 |
| Ct scan of chest with contrast | 11 | $2,655 | $221 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 12 | $2,548 | $196 |
| Isodose radiation therapy plan, complex | 14 | $2,352 | $124 |
| X-ray during radiation therapy | 39 | $935 | $13 |
| X-ray guidance for radiation therapy delivery | 11 | $916 | $70 |
| Blood test, comprehensive group of blood chemicals | 11 | $161 | $12 |
2013: 23 services
| Intensity modulated radiation treatment delivery per session | 49 | $228,746 | $396 |
| Radiation treatment delivery, three or more treatment areas | 61 | $88,570 | $227 |
| Ct guidance for insertion of radiation therapy fields | 98 | $75,294 | $111 |
| Radiation treatment delivery, three or more treatment areas | 38 | $74,233 | $246 |
| Design and construction of complex radiation treatment device | 73 | $50,500 | $141 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 66 | $41,704 | $509 |
| High precision radiation therapy planning | 21 | $40,226 | $1,916 |
| Radiation treatment management, 5 treatment sessions | 102 | $39,986 | $153 |
| Calculation of radiation therapy dose | 72 | $32,773 | $62 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 74 | $17,384 | $172 |
| 3d radiation therapy planning | 31 | $13,980 | $411 |
| New patient visit (60+ min) | 74 | $12,920 | $175 |
| Continuing radiation therapy consultation per week | 103 | $11,321 | $43 |
| Design and construction of radiation treatment device for high precision radiation therapy | 21 | $10,770 | $468 |
| Complex radiation therapy planning | 62 | $8,475 | $128 |
| Return visit (30+ min) | 51 | $5,377 | $87 |
| Long return visit (40+ min) | 29 | $4,327 | $124 |
| Special radiation treatment | 29 | $3,882 | $134 |
| Isodose radiation therapy plan, complex | 20 | $2,452 | $117 |
| Short return visit (20+ min) | 35 | $2,358 | $62 |
| Special radiation therapy planning for delivery of external radiation | 17 | $1,381 | $81 |
| X-ray during radiation therapy | 30 | $737 | $14 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 13 | $223 | $0 |
Medicaid work
$258,923 in 2024
Medicaid paid $258,923 for 1,485 billed services this clinician did in 2024, up to 23 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Computed tomography guidance for placement of radiation therapy fields | 644 | $81,413 |
| Radiation tx delivery imrt | 150 | $68,545 |
| Short return visit (20+ min) | 191 | $19,193 |
| Radiation treatment management, 5 treatments | 98 | $18,097 |
| Treatment devices, design and construction; complex (irregular blocks, special shields, compensators, wedges, molds or casts) | 55 | $15,921 |
| Radiation treatment delivery | 61 | $15,655 |
| Return visit (30+ min) | 99 | $13,517 |
| RADIATION PHYSICS CONSULT | 125 | $13,330 |
| Simple therapeutic radiology simulation-aided field setting | 32 | $8,812 |
| RADIATION THERAPY DOSE PLAN | 30 | $4,441 |
| 2024 | 1,485 | 10 | 23 | $258,923 |
| 2023 | 733 | 8 | 23 | $102,875 |
| 2022 | 342 | 3 | 20 | $55,582 |
| 2021 | 60 | 2 | 13 | $7,880 |
| 2020 | 101 | 1 | 13 | $12,184 |
| 2018 | 65 | 2 | 13 | $4,744 |
See the largest Medicaid services in earlier years
2023
| Computed tomography guidance for placement of radiation therapy fields | 309 | $38,208 |
| Radiation tx delivery imrt | 108 | $30,145 |
| Short return visit (20+ min) | 185 | $17,085 |
| Radiation treatment management, 5 treatments | 40 | $5,812 |
| Simple therapeutic radiology simulation-aided field setting | 17 | $4,216 |
| RADIATION PHYSICS CONSULT | 47 | $3,337 |
| Treatment devices, design and construction; complex (irregular blocks, special shields, compensators, wedges, molds or casts) | 14 | $2,604 |
| Return visit (30+ min) | 13 | $1,470 |
2022
| Computed tomography guidance for placement of radiation therapy fields | 238 | $35,774 |
| Treatment devices, design and construction; complex (irregular blocks, special shields, compensators, wedges, molds or casts) | 33 | $11,695 |
| RADIATION PHYSICS CONSULT | 71 | $8,114 |
2021
| Computed tomography guidance for placement of radiation therapy fields | 47 | $4,757 |
| New patient visit (60+ min) | 13 | $3,122 |
2020
| Computed tomography guidance for placement of radiation therapy fields | 101 | $12,184 |
2018
| Radiation treatment management, 5 treatments | 41 | $3,763 |
| RADIATION PHYSICS CONSULT | 24 | $981 |
Drugs they prescribed that Part D paid
$16,900
Pharmacies billed $16,900 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 21% of their Part D prescriptions (59 of 285) in 2024. Above the middle of the specialty; the typical radiation oncology clinician is at 11%.
259 generic and 26 brand-name prescriptions · $16,900 in drug cost · 33 antibiotic prescriptions to 27 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lidocaine Hcl Viscous | 20 | $545 | $27 |
| Hydrocodone-Acetaminophen | 21 | $302 | $14 |
| Oxycodone-Acetaminophen | 15 | $187 | $12 |
| Tamsulosin | 11 | $97 | $9 |
| Lorazepam | 13 | $16 | $1 |
Year by year
| 2024 | 285 | 94 | 21% (59) | 9% | $16,900 |
| 2023 | 259 | 75 | 15% (39) | 7% | $7,825 |
| 2022 | 251 | 88 | 16% (40) | 18% | $12,201 |
| 2021 | 270 | 87 | 11% (30) | 13% | $10,297 |
| 2020 | 175 | 58 | 24% (42) | None | $4,991 |
| 2019 | 290 | 94 | 24% (70) | None | $9,751 |
| 2018 | 329 | 94 | 20% (64) | None | $10,261 |
| 2017 | 170 | 79 | 12% (20) | None | $9,875 |
| 2016 | 150 | 59 | 27% (40) | 27% | $6,806 |
| 2015 | 226 | 75 | 23% (51) | None | $9,322 |
| 2014 | 182 | 63 | 17% (30) | None | $6,425 |
| 2013 | 158 | 69 | 30% (47) | None | $6,358 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Megestrol Acetate | 24 | $2,531 | $105 |
| Tamsulosin | 17 | $915 | $54 |
| Lidocaine Hcl Viscous | 22 | $443 | $20 |
| Hydrocodone-Acetaminophen | 15 | $212 | $14 |
| Gabapentin | 19 | $167 | $9 |
| Lorazepam | 14 | $19 | $1 |
2022: 6 drugs
| Ssd | 20 | $848 | $42 |
| Oxybutynin Chloride Er | 12 | $455 | $38 |
| Tamsulosin | 27 | $450 | $17 |
| Hydrocodone-Acetaminophen | 23 | $380 | $17 |
| Gabapentin | 25 | $259 | $10 |
| Lorazepam | 11 | $49 | $4 |
2021: 7 drugs
| Memantine | 19 | $1,244 | $65 |
| Oxybutynin Chloride Er | 17 | $643 | $38 |
| Ssd | 11 | $481 | $44 |
| Tamsulosin | 27 | $392 | $15 |
| Lidocaine Hcl Viscous | 11 | $337 | $31 |
| Hydrocodone-Acetaminophen | 13 | $161 | $12 |
| Lorazepam | 13 | $12 | $1 |
2020: 3 drugs
| Memantine | 11 | $326 | $30 |
| Hydrocodone-Acetaminophen | 20 | $315 | $16 |
| Pantoprazole | 14 | $91 | $7 |
2019: 7 drugs
| Ssd | 15 | $694 | $46 |
| Lidocaine Hcl Viscous | 26 | $661 | $25 |
| Hydrocodone-Acetaminophen | 30 | $553 | $18 |
| Nystatin | 11 | $541 | $49 |
| Tamsulosin | 16 | $290 | $18 |
| Hydromorphone | 17 | $139 | $8 |
| Lorazepam | 17 | $107 | $6 |
2018: 11 drugs
| Pilocarpine | 11 | $995 | $90 |
| Silver Sulfadiazine | 14 | $708 | $51 |
| Ssd | 12 | $605 | $50 |
| Hydromorphone | 24 | $303 | $13 |
| Lidocaine Hcl Viscous | 16 | $285 | $18 |
| Levofloxacin | 11 | $273 | $25 |
| Dexamethasone | 15 | $256 | $17 |
| Memantine | 14 | $240 | $17 |
| Hydrocodone-Acetaminophen | 19 | $189 | $10 |
| Lorazepam | 18 | $187 | $10 |
| Prednisone | 12 | $113 | $9 |
2017: 3 drugs
| Silver Sulfadiazine | 14 | $512 | $37 |
| Lidocaine Hcl Viscous | 17 | $492 | $29 |
| Fluconazole | 15 | $229 | $15 |
2016: 1 drug
| Morphine Sulfate | 13 | $215 | $17 |
2015: 5 drugs
| Carafate | 13 | $1,807 | $139 |
| Lidocaine Hcl Viscous | 21 | $443 | $21 |
| Tamsulosin | 11 | $440 | $40 |
| Nystatin | 13 | $413 | $32 |
| Hydrocodone-Acetaminophen | 17 | $308 | $18 |
2014: 2 drugs
| Carafate | 18 | $1,971 | $110 |
| Lidocaine Hcl Viscous | 17 | $296 | $17 |
2013: 4 drugs
| Carafate | 15 | $1,230 | $82 |
| Nystatin | 15 | $953 | $64 |
| Hydrocodone-Acetaminophen | 20 | $435 | $22 |
| Hydromorphone | 12 | $199 | $17 |
Money from drug and device companies
$1,684 in 2025
| 2025 | 31 | 76 | None | $1,684 |
| 2024 | 26 | 67 | None | $1,520 |
| 2023 | 25 | 46 | None | $1,145 |
| 2022 | 22 | 38 | None | $873 |
| 2021 | 14 | 44 | None | $877 |
| 2020 | 16 | 26 | None | $584 |
| 2019 | 20 | 39 | None | $979 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Rybrevant | $243 | 11 payments
|
| AstraZeneca Pharmaceuticals LP | Enhertu | $231 | 10 payments
|
| Merck Sharp & Dohme | Keytruda | $229 | 8 payments
|
| Regeneron Healthcare Solutions | Libtayo | $91 | 3 payments
|
| Abbvie | Epkinly | $76 | 3 payments
|
| Pharmacosmos Therapeutics | Monoferric | $69 | 3 payments
|
See all 73 published payments
| Merck Sharp & Dohme | Meals · 2025-11-10 | Keytruda | $26 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-07 | Imfinzi | $30 |
| Incyte | Meals · 2025-11-03 | Monjuvi | $22 |
| Janssen Biotech | Meals · 2025-10-28 | Erleada | $35 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-10-27 | None | $15 |
| Invivyd | Meals · 2025-10-27 | Pemgarda | $30 |
| Rigel Pharmaceuticals | Meals · 2025-10-24 | Tavalisse | $17 |
| Janssen Biotech | Meals · 2025-10-22 | Darzalex | $22 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-10-20 | Iclusig | $23 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-14 | Tagrisso | $26 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-13 | Enhertu | $20 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-07 | None | $14 |
| Genzyme | Meals · 2025-10-07 | Wayrilz | $27 |
| PharmaEssentia USA | Meals · 2025-10-06 | Besremi | $29 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-10-03 | None | $17 |
| TerSera Therapeutics | Meals · 2025-09-30 | Zoladex | $22 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-22 | Enhertu | $25 |
| PharmaEssentia USA | Meals · 2025-09-22 | Besremi | $18 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-21 | Enhertu | $14 |
| Lilly USA | Meals · 2025-09-15 | Verzenio | $22 |
| Regeneron Healthcare Solutions | Meals · 2025-09-12 | Lynozyfic | $23 |
| Novartis Pharmaceuticals | Meals · 2025-09-10 | Pluvicto | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-09 | Tagrisso | $21 |
| Heron Therapeutics | Meals · 2025-09-08 | Cinvanti | $17 |
| Tempus AI | Meals · 2025-09-03 | Xt Cdx | $16 |
| Regeneron Healthcare Solutions | Meals · 2025-08-29 | Libtayo | $35 |
| Abbvie | Meals · 2025-08-25 | Imbruvica | $28 |
| Merck Sharp & Dohme | Meals · 2025-08-25 | Keytruda | $29 |
| Pharmacosmos Therapeutics | Meals · 2025-08-25 | Monoferric | $21 |
| Agios Pharmaceuticals | Meals · 2025-08-22 | Pyrukynd | $23 |
| Abbvie | Meals · 2025-08-12 | Epkinly | $28 |
| Janssen Biotech | Meals · 2025-08-11 | Tecvayli | $24 |
| Pfizer | Meals · 2025-08-05 | Xtandi | $15 |
| Janssen Biotech | Meals · 2025-07-25 | Tecvayli | $17 |
| Novartis Pharmaceuticals | Meals · 2025-07-24 | Pluvicto | $19 |
| Merck Sharp & Dohme | Meals · 2025-07-22 | Keytruda | $35 |
| Merck Sharp & Dohme | Meals · 2025-07-18 | Keytruda | $29 |
| BeOne Medicines USA | Meals · 2025-07-15 | Tevimbra | $30 |
| Genmab U.S. | Meals · 2025-07-14 | Epkinly | $27 |
| Pharmacosmos Therapeutics | Meals · 2025-07-11 | Monoferric | $21 |
| Astellas Pharma US | Meals · 2025-07-07 | Vyloy | $26 |
| Iovance Biotherapeutics | Meals · 2025-07-01 | Amtagvi | $19 |
| Janssen Biotech | Meals · 2025-06-25 | Erleada | $18 |
| Lilly USA | Meals · 2025-06-23 | Verzenio | $18 |
| Merck Sharp & Dohme | Meals · 2025-06-16 | Keytruda | $26 |
| TerSera Therapeutics | Meals · 2025-06-16 | Zoladex | $24 |
| Merck Sharp & Dohme | Meals · 2025-06-06 | Keytruda | $27 |
| Sun Pharmaceutical Industries | Meals · 2025-06-06 | Odomzo | $16 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-06-05 | Iclusig | $24 |
| Janssen Biotech | Meals · 2025-06-04 | Rybrevant | $26 |
| Daiichi Sankyo | Meals · 2025-06-03 | Enhertu | $21 |
| Sun Pharmaceutical Industries | Meals · 2025-05-23 | Odomzo | $19 |
| Janssen Biotech | Meals · 2025-05-09 | Tecvayli | $28 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-06 | Enhertu | $28 |
| Alexion Pharmaceuticals | Meals · 2025-04-25 | Ultomiris | $20 |
| Merck Sharp & Dohme | Meals · 2025-04-25 | Keytruda | $31 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-11 | Calquence | $22 |
| Taiho Oncology | Meals · 2025-04-04 | Lonsurf | $18 |
| Merck Sharp & Dohme | Meals · 2025-03-24 | Keytruda | $26 |
| Janssen Biotech | Meals · 2025-03-21 | Rybrevant | $25 |
| Janssen Biotech | Meals · 2025-03-21 | Rybrevant | $2 |
| Regeneron Healthcare Solutions | Meals · 2025-03-18 | Libtayo | $33 |
| TerSera Therapeutics | Meals · 2025-03-18 | Zoladex | $20 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-05 | Enhertu | $33 |
| Genentech USA | Meals · 2025-03-05 | Itovebi | $18 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-03-04 | Nubeqa | $28 |
| Abbvie | Meals · 2025-03-01 | Epkinly | $20 |
| Alexion Pharmaceuticals | Meals · 2025-02-25 | Ultomiris | $31 |
| Sobi | Meals · 2025-02-18 | Vonjo | $14 |
| Sun Pharmaceutical Industries | Meals · 2025-02-04 | Yonsa | $16 |
| Janssen Biotech | Meals · 2025-01-21 | Rybrevant | $32 |
| Pharmacosmos Therapeutics | Meals · 2025-01-16 | Monoferric | $26 |
| Janssen Biotech | Meals · 2025-01-02 | Erleada | $13 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,520
| Merck Sharp & Dohme | Keytruda | $234 | 9 payments
|
| Janssen Biotech | Erleada | $179 | 10 payments
|
| Lilly USA | Verzenio | $124 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Imfinzi | $103 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Fruzaqla | $99 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Gilotrif | $79 | 4 payments
|
| Incyte | Monjuvi | $73 | 4 payments
|
| Genmab U.S. | Epkinly | $72 | 3 payments
|
| Genentech USA | Tecentriq | $63 | 2 payments
|
| Pfizer | Ibrance | $60 | 3 payments
|
| PharmaEssentia USA | Besremi | $47 | 2 payments
|
| Coherus Biosciences | Udenyca | $46 | 2 payments
|
| Eisai | Lenvima | $39 | 2 payments
|
| Novartis Pharmaceuticals | Pluvicto | $37 | 2 payments
|
| SpringWorks Therapeutics | Ogsiveo | $30 | 1 payment
|
| Aveo Pharmaceuticals | Fotivda | $27 | 1 payment
|
| BeiGene USA | Brukinsa | $24 | 1 payment
|
| Pharmacosmos Therapeutics | Monoferric | $23 | 1 payment
|
| Rigel Pharmaceuticals | Rezlidhia | $22 | 1 payment
|
| TerSera Therapeutics | Zoladex | $21 | 1 payment
|
| Deciphera Pharmaceuticals | Qinlock | $21 | 1 payment
|
| Spectrum Pharmaceuticals | Rolvedon | $20 | 1 payment
|
| Cardinal Health 414 | Kit for the Preparation of Lymphoseek (Technetium Tc 99m Tilmanocept) | $20 | 1 payment
|
| Daiichi Sankyo | Enhertu | $19 | 1 payment
|
| Regeneron Healthcare Solutions | Libtayo | $19 | 1 payment
|
| EMD Serono | None | $17 | 1 payment
|
2023: $1,145
| Janssen Biotech | Erleada | $132 | 4 payments
|
| Myriad Genetic Laboratories | Precisetumor | $104 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Ninlaro | $94 | 5 payments
|
| Genentech USA | Lunsumio | $68 | 2 payments
|
| Incyte | None | $65 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Calquence | $63 | 3 payments
|
| Organon | Ontruzant | $62 | 4 payments
|
| Sobi | Doptelet | $58 | 3 payments
|
| Pfizer | Ibrance | $52 | 2 payments
|
| Merck Sharp & Dohme | Keytruda | $49 | 2 payments
|
| Pharmacyclics LLC An AbbVie | Imbruvica | $43 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | None | $42 | 2 payments
|
| Exelixis | Cabometyx | $36 | 1 payment
|
| Genzyme | Jevtana | $35 | 1 payment
|
| Novartis Pharmaceuticals | Pluvicto | $29 | 1 payment
|
| Lilly USA | Jaypirca | $28 | 1 payment
|
| Sumitomo Pharma America | Orgovyx | $27 | 1 payment
|
| Eisai | Lenvima | $25 | 1 payment
|
| AVEO Pharmaceuticals | Fotivda | $23 | 1 payment
|
| Regeneron Healthcare Solutions | Libtayo | $21 | 1 payment
|
| Seagen | Padcev | $19 | 1 payment
|
| BeiGene USA | Brukinsa | $19 | 1 payment
|
| Accord Healthcare | Camcevi | $17 | 1 payment
|
| Spectrum Pharmaceuticals | Rolvedon | $17 | 1 payment
|
| Coherus Biosciences | Udenyca | $17 | 1 payment
|
2022: $873
| Dendreon Pharmaceuticals | Provenge | $104 | 3 payments
|
| Amgen | Kyprolis | $103 | 4 payments
|
| Pharmacyclics LLC an AbbVie | Imbruvica | $74 | 3 payments
|
| Jazz Pharmaceuticals | Zepzelca | $71 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Imfinzi | $62 | 3 payments
|
| Regeneron Healthcare Solutions | Libtayo | $55 | 2 payments
|
| Merck Sharp & Dohme | Keytruda | $46 | 2 payments
|
| Seagen | Tukysa | $41 | 2 payments
|
| Genzyme | Jevtana | $39 | 1 payment
|
| Davol | Phasix Mesh | $29 | 1 payment
|
| Novartis Pharmaceuticals | None | $29 | 2 payments
|
| BeiGene USA | Brukinsa | $28 | 2 payments
|
| Janssen Biotech | Erleada | $26 | 1 payment
|
| Eisai | Lenvima | $25 | 1 payment
|
| Organon | Ontruzant | $24 | 1 payment
|
| Sobi | Doptelet | $22 | 1 payment
|
| Rigel Pharmaceuticals | Tavalisse | $21 | 1 payment
|
| Deciphera Pharmaceuticals | Qinlock | $17 | 1 payment
|
| Acrotech Biopharma | Beleodaq | $17 | 1 payment
|
| Incyte | Monjuvi | $15 | 1 payment
|
| Lilly USA | Retevmo | $13 | 1 payment
|
| Global Blood Therapeutics | Oxbryta | $13 | 1 payment
|
2021: $877
| Pharmacyclics LLC An AbbVie | Imbruvica | $178 | 9 payments
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $135 | 8 payments
|
| Merck Sharp & Dohme | Keytruda | $120 | 6 payments
|
| Amgen | Kyprolis | $100 | 4 payments
|
| Myovant Sciences | Orgovyx | $69 | 3 payments
|
| Janssen Biotech | Darzalex | $58 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Ninlaro | $53 | 2 payments
|
| BeiGene USA | Brukinsa | $47 | 3 payments
|
| Jazz Pharmaceuticals | Zepzelca | $24 | 1 payment
|
| AbbVie | Venclexta | $24 | 1 payment
|
| Daiichi Sankyo | Injectafer | $22 | 1 payment
|
| Heron Therapeutics | Cinvanti | $18 | 1 payment
|
| GlaxoSmithKline | Zejula | $17 | 1 payment
|
| Lilly USA | Cyramza | $11 | 1 payment
|
2020: $584
| Merck Sharp & Dohme | Keytruda | $140 | 8 payments
|
| Novocure | Oncology | $83 | 1 payment
|
| AbbVie | Venclexta | $57 | 2 payments
|
| Pharmacyclics LLC An AbbVie | Imbruvica | $54 | 2 payments
|
| Davol | Bd Max | $39 | 2 payments
|
| Janssen Biotech | Erleada | $24 | 1 payment
|
| Celgene | Pomalyst | $23 | 1 payment
|
| Eisai | Lenvima | $23 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $22 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $21 | 1 payment
|
| Aurobindo Pharma USA | Beleodaq | $19 | 1 payment
|
| Ipsen Biopharmaceuticals | Somatuline Depot | $17 | 1 payment
|
| Lilly USA | Verzenio | $16 | 1 payment
|
| Incyte | Jakafi | $16 | 1 payment
|
| Novartis Pharmaceuticals | Mekinist | $15 | 1 payment
|
| Jazz Pharmaceuticals | Zepzelca | $13 | 1 payment
|
2019: $979
| AstraZeneca Pharmaceuticals LP | Lynparza | $255 | 3 payments
|
| Novartis Pharmaceuticals | Promacta | $102 | 5 payments
|
| Merck Sharp & Dohme | Keytruda | $87 | 5 payments
|
| Amgen | Kanjinti | $80 | 3 payments
|
| Celgene | Revlimid | $65 | 3 payments
|
| Janssen Biotech | Zytiga | $44 | 2 payments
|
| Focal Therapeutics | Biozorb | $44 | 2 payments
|
| Tesaro | Zejula | $43 | 2 payments
|
| Seattle Genetics | Adcetris | $30 | 1 payment
|
| Lilly USA | Verzenio | $29 | 2 payments
|
| Lexicon Pharmaceuticals | Xermelo | $27 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Vitrakvi | $25 | 1 payment
|
| Exelixis | Cabometyx | $23 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | None | $22 | 1 payment
|
| Astellas Pharma US | Xtandi | $20 | 1 payment
|
| Pharmacyclics LLC An AbbVie | Imbruvica | $18 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $18 | 1 payment
|
| Array BioPharma | Braftovi | $18 | 1 payment
|
| Eisai | Lenvima | $15 | 1 payment
|
| Pfizer | Ibrance | $12 | 1 payment
|
Professional record
- NPI
- 1306839915
- Licence
- FL ME89834Florida ME89834: Inactive
- Group
- Epic Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2085R0001X (2085R0001X)
- Mailing address
- 6380 Clark Ave, Dublin, CA, 94568
- NPI first listed
- 2005-08-30
- NPI last updated
- 2013-05-13
This is when the NPI record was last certified, not a medical board exam.